Beranda › Glomerulosklerosis Segmental Fokal › Michigan › Ann Arbor
Uji klinis Glomerulosklerosis Segmental Fokal di Ann Arbor, MI
6 studi untuk Glomerulosklerosis Segmental Fokal mencari peserta di lokasi sekitar Ann Arbor (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
Menerima pesertaFase 2
- University of Michigan Health System - Ann Arbor- Site Number : 8400010, Ann Arbor
Nephrotic Syndrome Study Network
Menerima pesertaStudi observasional
- CS Mott Children's Hospital, University of Michigan, Ann Arbor
- University of Michigan Medical Center, Ann Arbor
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Menerima pesertaFase 2
- C.S. Mott Children's Hospital, Ann Arbor
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Menerima pesertaFase 3
- University of Michigan, Ann Arbor
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
Menerima pesertaStudi observasional
- University of Michigan, Ann Arbor
Uji klinis Glomerulosklerosis Segmental Fokal di kota lain
- Philadelphia, PA9 studi
- Durham, NC8 studi
- New York City, NY7 studi
- Queens, NY6 studi
- Miami, FL6 studi
- Los Angeles, CA6 studi
- Houston, TX5 studi
- Atlanta, GA5 studi
- Cleveland, OH4 studi
- Chicago, IL4 studi
- Dallas, TX4 studi
- Kansas City, MO4 studi
Studi lain di Ann Arbor
- Kanker Prostat27 studi
- Kanker Payudara26 studi
- Kanker Paru Non-Sel Kecil26 studi
- Kanker (semua jenis)25 studi
- Kanker Kolorektal23 studi
- Kanker Paru23 studi
- Gagal Jantung22 studi
- Leukemia Mieloid Akut17 studi
- Penyakit Kardiovaskular16 studi
- Kanker Pankreas14 studi
- Melanoma12 studi
- Kanker Ginjal (Karsinoma Sel Renal)12 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.